A Possible Therapeutic Role for Adenosine During Inflammation
NCT00513110
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Endotoxemia
Interventions
GENETIC:
AMPD1 polymorphism
DRUG:
Caffeine infusion
DRUG:
placebo
Sponsor
Radboud University Medical Center